Light Mode
$5.08 ↑ +0.03 (+0.59%) Trading Up from the previous close of $5.05, $0.09 below the day’s high of $5.17
+2.94 (+130.67%) / 6M
Momentum, market sentiment, and recent alerts
AEMD reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -1.0%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce on April 17, 1991 and is headquartered in San Diego, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.